Equity
Total Liabilities & Equity
Pfizer Total Liabilities & Equity decreased by 0.3% to $207.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $208.03B to $207.62B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows an upward trend with a 6.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Growth in this figure indicates an expansion of the company's asset base, typically funded by either debt or equity issuance.
Detailed definition
This is the total sum of all financial obligations and shareholder equity, which must mathematically equal the company's...
Peer comparison
Standard across all industries as a mandatory balance sheet identity.
Metric ID:
total_liabilities_and_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $169.92B | $179.19B | $181.48B | $183.84B | $195.29B | $195.35B | $197.21B | $195.62B | $220.17B | $215.02B | $226.50B | $221.10B | $216.19B | $219.48B | $213.40B | $208.03B | $206.10B | $208.73B | $208.16B | $207.62B |
| QoQ Change | — | +5.5% | +1.3% | +1.3% | +6.2% | +0.0% | +0.9% | -0.8% | +12.6% | -2.3% | +5.3% | -2.4% | -2.2% | +1.5% | -2.8% | -2.5% | -0.9% | +1.3% | -0.3% | -0.3% |
| YoY Change | — | — | — | — | +14.9% | +9.0% | +8.7% | +6.4% | +12.7% | +10.1% | +14.9% | +13.0% | -1.8% | +2.1% | -5.8% | -5.9% | -4.7% | -4.9% | -2.5% | -0.2% |
Range$169.92B – $226.50B
CAGR+4.3%
Avg YoY Growth+4.1%
Median YoY Growth+4.2%
Current Streak2 quarters decline
Total Liabilities & Equity at Other Companies
Frequently Asked Questions
- What is Pfizer's total liabilities & equity?
- Pfizer (PFE) reported total liabilities & equity of $207.62B in Q1 2026.
- How has Pfizer's total liabilities & equity changed year-over-year?
- Pfizer's total liabilities & equity decreased by 0.2% year-over-year, from $208.03B to $207.62B.
- What is the long-term trend for Pfizer's total liabilities & equity?
- Over 5 years (2020 to 2025), Pfizer's total liabilities & equity has grown at a 6.2% compound annual growth rate (CAGR), from $154.23B to $208.16B.
- What does total liabilities & equity mean?
- The total value of all company assets, balanced by its debts and shareholder equity.